News & Insights
Find up-to-date information and news regarding important policy and industry updates affecting the long-term care pharmacy community. This page is updated regularly to include new research and federal policy impacts on this community.
Press Releases & Statements
As the only national organization exclusively representing the interests of LTC pharmacies, hear directly from SCPC.
Comment Letters
06/24/2022
Senior Care Pharmacy Coalition Provides Comments on the Food and Drug Administration’s Proposed Opioid Mail-Back Notice
The Senior Care Pharmacy Coalition (SCPC) has submitted a comment letter to the Food and Drug Administration (FDA) regarding the agency’s notice of a policy to require that pharmacies include a “mail-back” envelope with every prescription dispensed in an outpatient setting. The notice, which is not a formal proposal to change existing policy, concerns a policy that would modify the current Opioid Analgesic Risk Evaluation and Mitigation Strategy.
Read MoreComment Letters
06/08/2022
Senior Care Pharmacy Coalition Applauds Federal Trade Commission Vote to Investigate Pharmacy Benefit Managers, Introduction of The Pharmacy Benefit Manager Transparency Act of 2022 by Senators Grassley and Cantwell
The Senior Care Pharmacy Coalition (SCPC), the only Washington-based organization exclusively representing the interests of long-term care (LTC) pharmacies applauds the Federal Trade Commission (FTC) for yesterday’s decision by to investigate Pharmacy Benefit Managers (PBMs) and the vertically integrated health care conglomerates which own them.
Read MoreReleases & Statements
05/05/2022
Bring it on home: Obstacles and opportunities in bringing long-term care pharmacy services to Medicare beneficiaries living at home
By Alan Rosenbloom As anyone who has been prescribed medication knows, pharmacies play a crucial role in our health care system. This is especially true for older people, since their reliance on medications to treat their overall health care needs increases. While younger, healthier people can turn to a local retail pharmacist, people with medically […]
Read MoreIn The News
Recent coverage of SCPC in the news.
In the News
06/22/2022
Check out SCPC CEO Alan Rosenbloom on the Pharmacy Podcast Network’s “PBM Reform Podcast”
SCPC President and CEO Alan Rosenbloom speaks with the Pharmacy Podcast Network about the impact of the Pharmacy Benefit Manager Transparency Act of 2022 on the Pharmacy Profession. He is joined by Michael Baxter, Senior Director of Regulatory Policy at APhA and Todd Eury with the Pharmacy Podcast Network. Listen here.
Read MoreIn the News
05/03/2022
Free market is at risk because of PBM titans’ anti-competitive behaviors
Congress must thoroughly investigate the anti-competitive behaviors of these conglomerates and act accordingly. Doing so will provide better outcomes both for patients and a more competitive marketplace for unaffiliated pharmacies. By Alan Rosenbloom We’ve been here before, right? A Congress and Administration eager to talk about mysterious escalating prescription drug prices. Over the years, both […]
Read MoreIn the News
02/18/2022
Senior-Care Pharmacies Oppose Pharmacy Concession Proposal
By John Wilkerson, Inside Health Policy Contrary to independent retail pharmacies, long-term care pharmacies oppose CMS’ proposal to make Part D plans give concessions they receive from network pharmacies to beneficiaries at the point of sale. Senior Care Pharmacy Coalition President and CEO Alan Rosenbloom said the proposed policy would legitimize what he called illegitimate […]
Read MoreOur Videos
SCPC welcomes the opportunity to highlight the work of the LTC pharmacy community. To learn more about the LTC pharmacy sector, click the link below and watch the videos highlighting the important, unique work our members do in their communities.
Policy & Sector Insights
The LTC pharmacy sector is in constant change with new research, policies and news.
Policy & Sector Insights
01/07/2022
Prescription Drug Policy, 2021 And 2022: The Year In Review, And The Year Ahead
By Rachel Sachs Health Affairs This past year was filled with news in the prescription drug policy area, from the Food and Drug Administration’s (FDA) most controversial drug approval in many years to ongoing discussions in Congress over drug pricing reform. Through it all, the importance of responding to the COVID-19 pandemic has remained at […]
Read MorePolicy & Sector Insights
12/16/2021
Why the big questions about drug prices are rarely asked: It’s hard to do
By Fred D. Ledley STAT News Public debate over legislation to allow Medicare to negotiate the price of drugs has been dominated by stories of personal suffering caused by high drug prices, accounts of lifesaving cures provided by pharmaceutical innovations, and arguments regarding nuanced economic models of how reducing drug prices could affect government spending and pharmaceutical innovation. Big questions related […]
Read MorePolicy & Sector Insights
11/30/2021
21st Annual Transamerica Retirement Survey of Workers
A Compendium of Findings About the Retirement Outlook of U.S. Workers By Catherine Collinson, Patti Rowey, Heidi Cho Transamerica Center for Retirement Studies A Compendium of Findings About the Retirement Outlook of U.S. Workers (“Compendium”), a collaboration between nonprofit Transamerica Institute® and its Transamerica Center for Retirement Studies® (TCRS), explores the health, employment, and finances […]
Read More